| Literature DB >> 16085019 |
Robert L Goldenberg1, Jennifer F Culhane, Derek C Johnson.
Abstract
Adverse pregnancy outcomes can follow direct placental, fetal, or neonatal infection, or preterm birth associated with vaginal, cervical, intrauterine, or even nonpelvic infections. These latter infections appear to be associated with the majority of very early preterm births, and may explain some of the long-term neurologic damage associated with preterm birth. Bacterial vaginosis and its associated intrauterine infections likely contribute far more to the overall burden of adverse pregnancy outcomes than the more classical perinatal infections such as rubella and syphilis.Entities:
Mesh:
Year: 2005 PMID: 16085019 PMCID: PMC7119141 DOI: 10.1016/j.clp.2005.04.006
Source DB: PubMed Journal: Clin Perinatol ISSN: 0095-5108 Impact factor: 3.430
Maternal infections and stillbirths
| Organism | Maternal disease | Comment |
|---|---|---|
| Spirochetes | ||
| | Syphilis | Major cause of SB when maternal prevalence is high |
| | Lyme disease | Confirmed, but not a common cause of SB |
| | Tick-borne | Of unknown importance as a cause of SB |
| Relapsing fever | ||
| | Leptospirosis | Confirmed, but not a common cause of SB |
| Protozoa | ||
| | Trypanosomiasis | Not a certain cause of SB |
| | Chagas disease | Confirmed as a cause of SB in South America but of unknown importance |
| | Malaria | Likely an important cause of SB in newly endemic areas or in newly infected women |
| | Toxoplasmosis | Confirmed, but not a common cause of SB |
| | Q fever | Confirmed as a cause of SB but of unknown importance |
| Viruses | ||
| Parvovirus (B-19) | Erythema infectiosum | Confirmed as a cause of SB and likely the most common viral etiologic agent |
| Coxsackie A & B | Various presentations | Confirmed as causes of SB and may be an important contributor |
| Echovirus | Various presentations | Confirmed as a cause of SB but of unknown importance |
| Enterovirus | Various presentations | Confirmed as a cause of SB but of unknown importance |
| Polio virus | Polio | Historically a cause of SB but since routine vaccination no longer seen in developed countries |
| Varicella-zoster | Chickenpox | Confirmed, but not a common cause of SB |
| Rubella | German measles | Confirmed, but no longer a cause of SB in developed countries |
| Mumps | Parotitis | Possibly historically, but no longer a cause of SB in developed countries |
| Rubeola | Measles | Possibly a cause of SB historically |
| Cytomegalovirus | Generally asymptomatic in adults | Rarely if ever a cause of SB |
| SARS virus | Respiratory illness | Case reports |
| Variola | smallpox | Historically a cause of SB but no longer seen |
| Lymphocytic choriomeningitis virus | Lymphocytic choriomeningitis | Not confirmed as a cause of SB and of unknown importance |
| HIV | AIDS | Associated with SB, but not likely causative |
| Bacteria | ||
| | Generally asymptomatic | Confirmed and probably the most common organism associated with SB |
| Group B streptococcus | Generally asymptomatic | Confirmed as a common cause of SB |
| Klebsiella | Generally asymptomatic | Confirmed as a common cause of SB |
| Enterococcus | Generally asymptomatic | Confirmed |
| Ureaplasma urealyticum | Generally asymptomatic | Confirmed |
| | Generally asymptomatic | Confirmed |
| Bacteroidaceae | Generally asymptomatic | Confirmed |
| | Listerosis | Confirmed, generally transmitted transplacentally |
| Other bacteria including brucellosis, clostridia, agrobacterium radiobacter, salmonella, pseudomonas, etc. | Suggested by case reports | |
| | Pelvic infection | Suggested by case reports |
| | Pelvic infection | Suggested by case reports |
| | Tuberculosis | Confirmed by case reports, but rare in developed countries |
| Fungi | ||
| | Thrush, vaginitis | Confirmed as a cause of SB by case reports |
Data from Goldenberg RL, Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol 2003;189:863.
Adverse reproductive outcomes associated with maternal infection
| Maternal colonization/ organism | Infertility | Abortion | Congenital anomalies | Stillbirth | IUGR | Preterm birth | Neonatal death | Postnatal disease | Long-term disability | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deafness | Eye disease | Neurologic | |||||||||
| Bacterial vaginosis | − | − | − | − | − | + | − | − | − | − | − |
| Chlamydia | + | − | − | − | − | + | − | + | − | + | − |
| Coxsackievirus | − | − | ± | + | − | − | − | − | − | − | ± |
| Cytomegalovirus | − | − | − | − | + | + | + | + | + | + | + |
| Echovirus | − | − | − | ± | − | − | + | − | − | − | − |
| Gonorrhoea | + | − | − | − | − | + | − | − | − | + | − |
| Group B streptococcus | − | − | − | + | − | − | + | + | − | − | + |
| Hepatitis B | − | − | − | − | − | − | − | + | − | − | − |
| Hepatitis C | − | − | − | − | − | − | − | + | − | − | − |
| Herpes simplex | − | − | − | − | − | − | + | + | − | + | + |
| HIV | − | − | − | − | ± | ± | − | + | − | − | ± |
| HPV | − | − | − | − | − | − | − | + | − | − | − |
| Influenza | − | + | − | ± | − | + | − | − | − | − | − |
| − | + | − | + | + | + | + | + | − | − | + | |
| Lyme borreliosis | − | − | − | + | + | ± | − | − | − | − | ± |
| Malaria | − | + | − | + | + | ± | − | − | − | − | − |
| Measles | − | − | − | − | + | + | + | + | − | − | − |
| Mumps | + | ± | − | ± | − | − | − | − | − | − | − |
| Parvovirus | − | + | − | + | − | − | − | − | − | − | − |
| Rubella | − | ± | + | + | + | − | + | + | + | + | + |
| SARS | − | + | − | + | ± | ± | − | − | − | − | − |
| Syphilis | − | + | + | + | + | + | + | + | + | − | + |
| Toxoplasmosis | − | + | − | + | + | − | − | − | − | + | + |
| − | − | − | − | − | + | − | − | − | − | − | |
| Tuberculosis | − | − | − | ± | − | − | + | + | − | − | − |
| Varicella | − | − | + | ± | + | + | + | + | − | + | + |
−, Occurs rarely if at all; +, established relationship; ±, may occur, uncommon.
Data from Refs. [75], [134], [135], [136].
Perinatal transmission of major human pathogens
| Maternal infection/organism | Approximate maternal prevalence (%) | Usual timing of transmission | Neonates infected/ colonized (%) when mother colonized and not treated | |
|---|---|---|---|---|
| Prenatal | Intrapartum | |||
| Bacterial vaginosis | 20.0 | − | − | 0 |
| Chlamydia | 5.0 | − | + | 50.0 |
| Coxsackievirus | 1.0 | + | − | ± |
| Cytomegalovirus | 33.0 | + | + | 3.0 |
| Echovirus | Variable | − | + | ± |
| Gonorrhoea | 1.0 | − | + | 50.0 |
| Group B streptococcus | 20.0 | ± | + | 50.0 |
| Hepatitis B | 0.2 | − | + | 30.0 |
| Hepatitis C | 2.0 | − | + | 8 |
| Herpes simplex | 20.0 | ± | + | 0.2 |
| HIV | 0.2 | + | + | 25.0 |
| HPV | 5.0 | − | + | 5.0 |
| Influenza | Variable | + | − | ± |
| Rare | + | − | ± | |
| Lyme borreliosis | 0.1 | + | − | ± |
| Malaria | Variable | + | − | 4.0 |
| Measles (rubeola) | Rare | + | − | ± |
| Mumps | Rare | + | − | ± |
| Parvovirus | 1.0 | + | − | 20.0 |
| Rubella | Rare | + | − | 50.0 |
| Syphilis | 0.12 | + | ± | 40.0 |
| Toxoplasmosis | 1.0 | + | − | 30.0 |
| 5.0 | − | − | 0 | |
| Tuberculosis | Rare | + | − | ± |
| Varicella | Rare | + | + | 2.0 |
+, Established relationship; ±, may occur, uncommon; −, occurs rarely if at all.
Data from Refs. [75], [134], [135], [136].
By serology.
The estimated impact of direct fetal and neonatal infection with various infections on adverse outcomes of pregnancy each year in the 4,000,000 United States births
| Maternal infection/ organism | Approximate maternal prevalence (%) | Mothers infected/ colonized (no.) | With current treatment in the United States, of infected mothers, % and no. of infants colonized | Adverse outcomes of fetal neonatal infection/colonized | ||||
|---|---|---|---|---|---|---|---|---|
| % | No. | Neonatal disease without sequelae | Perinatal death | Neurologic sequelae | New onset post-neonatal illness and death | |||
| Bacterial vaginosis | 20.0 | 800,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Chlamydia | 5.0 | 200,000 | 50.0 | 100,000 | 20,000 | 0 | 0 | 0 |
| Cytomegalovirus | 33.0 | 1,300,000 | 3.0 | 40,000 | ± | 300 | 2000 | 5000 |
| Gonorrhea | 1.0 | 40,000 | 50.0 | 20,000 | ± | ± | ± | 0 |
| Group B streptococcus | 20.0 | 800,000 | 12.5 | 100,000 | 1200 | 150 | 150 | — |
| Hepatitis B | 0.2 | 8000 | 10.0 | 800 | 0 | 0 | 0 | 300 |
| Herpes simplex | 20.0 | 800,000 | 0.15 | 1200 | 400 | 400 | 400 | 0 |
| HIV | 0.2 | 8000 | 1.0 | 80 | 0 | 0 | 0 | 80 |
| Rubella | Rare | — | — | — | 0 | 0 | 0 | 0 |
| Syphilis | 0.12 | 4800 | 40.0 | 1920 | 720 | 720 | 600 | 0 |
| 5.0 | 200,000 | 0 | 0 | 0 | 0 | 0 | 0 | |
±, Occurs, but rarely.
Data from Refs. [75], [135], [136].
Assumes prophylaxis for eye disease.
Mild pneumonia.
Hearing loss.
Assuming current screening and treatment programs reduce transmission by 75% and that 1.5% of colonized infants develop sepsis.
Assuming current screening and treatment programs reduce transmission by 70%.
Assuming current screening and treatment programs reduce transmission to 1%.
The estimated impact of various infections on adverse outcomes of pregnancya through their effect on preterm birth
| Maternal infection/ organism | Approximate maternal prevalence (%) | Mothers infected (no.) | Estimated increase in preterm birth | Estimated excess preterm birth | Adverse outcomes linked to preterm birth | |
|---|---|---|---|---|---|---|
| Perinatal death (no.) | Neurologic sequelae (no.) | |||||
| Bacterial vaginosis | 20.0 | 800,000 | 2× | 80,000 | 4000 | 4000 |
| Chlamydia | 5.0 | 200,000 | 2× | 20,000 | 1000 | 1000 |
| Cytomegalovirus | 33.0 | 1,300,000 | — | — | — | |
| Gonorrhea | 1.0 | 40,000 | 3× | 8,000 | 400 | 400 |
| Group B streptococcus | 20 | 80,000 | — | — | — | |
| Hepatitis B | 1.0 | 40,000 | — | — | — | |
| Herpes simplex | 20.0 | 800,000 | — | — | — | |
| HIV | 0.2 | 8000 | — | — | — | |
| Rubella | 0 | 0 | — | — | — | |
| Syphilis | 0.12 | 4800 | 2× | 480 | 24 | 24 |
| 2.0 | 80,000 | 1.3 | 2400 | 120 | 120 | |
Data from Refs. [75], [135].
Assuming 4,000,000 births per year.
Based on best available data in untreated women.
Assuming a baseline preterm rate of 10%.
Assuming 5% deaths and 5% neurologic sequelae.
Insufficient evidence for a causative relationship.